Frampton
Catherine H. Frampton, Oxford GB
Patent application number | Description | Published |
---|---|---|
20150240181 | LUBRICATING OIL COMPOSITION - A low sulphated ash lubricating oil composition comprising an overbased magnesium salicylate detergent and an ashless alkylene bis(dihydrocarbyldithiocarbamate) which exhibits an extended drain interval. | 08-27-2015 |
Christopher Frampton, Suffolk GB
Patent application number | Description | Published |
---|---|---|
20110086891 | Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide) - This invention relates to solid forms of 2-(2,4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide and pharmaceutical compositions thereof, and methods and uses therewith. | 04-14-2011 |
20130158083 | METAXALONE COCRYSTALS - The invention relates to improvements of the physiochemical and/or the pharmaceutical properties of metaxalone. Disclosed herein are several new cocrystals of metaxalone, including: a 1:1 metaxalone adipic acid cocrystal, a 1:0.5 metaxalone fumaric acid cocrystal, a 1:1 metaxalone salicyclic acid cocrystal, a 1:0.5 metaxalone succinic acid cocrystal, and a 1:0.5 metaxalone maleic acid cocrystal. The therapeutic uses of these metaxalone cocrystals are described as well as therapeutic compositions containing them. | 06-20-2013 |
20130203806 | CILOSTAZOL COCRYSTALS AND COMPOSITIONS - The invention relates to improvements of the physiochemical and/or the pharmaceutical properties of cilostazol. Disclosed herein are several new compositions and cocrystals of cilostazol, including: a 1:1 cilostazol gentisic acid cocrystal, a 1:1:1 cilostazol gentisic acid H | 08-08-2013 |
Christopher Frampton, Stowmarket Suffolk GB
Patent application number | Description | Published |
---|---|---|
20140343060 | APREPITANT L-PROLINE SOLVATES - COMPOSITIONS AND COCRYSTALS - Aprepitant L-proline solvate compositions and aprepitant L-proline solvate cocrystals are disclosed as well as pharmaceutical compositions containing them. The compositions and cocrystals of the invention are: 1:1:1 aprepitant L-proline methanol composition; a 1:1:1 aprepitant L-proline methanol cocrystal; a 1:1:1:1 aprepitant L-proline ethanol composition; a 1:1:1 aprepitant L-proline ethanol cocrystal; l 1:1:1 aprepitant L-proline n-propanol composition; and a 1:1:1 aprepitant L-proline n-propanol cocrystal: The aprepitant L-proline solvate compositions or cocrystals may be used in the same way as aprepitant to treat or prevent disorders relating to emesis, a neuropsychiatric disease, an inflammatory disease, pain, cancer, a skin disease, itch a respiratory disease, or an addiction. | 11-20-2014 |
Christopher Frampton, Stowmarket GB
Patent application number | Description | Published |
---|---|---|
20130252949 | APREPITANT L-PROLINE COMPOSITION AND COCRYSTAL - A 1:1:1 aprepitant L-proline H | 09-26-2013 |
20150119428 | TRANILAST COMPOSITIONS AND COCRYSTALS - Mew tranilast complexes and new tranilast cocrystals are disclosed. These include all tranilast nicotinamide complex, a 1:1 tranilast nicotinamide cocrystal, a 1:1 tranilast saccharin complex, a 1:1 tranilast saccharin cocrystal, a 1:1 tranilast gentisic acid complex, a 1:1 tranilast gentisic acid cocrystal, a 1:1 tranilast salicylic acid complex, a 1:1 tranilast salicylic acid cocrystal, a 1:1 tranilast urea complex, a 1:1 tranilast urea cocrystal, a 1:1 tranilast 4-amtnoben2oic acid complex, a 1:1 tranilast 4-am!nobers2oic acid cocrystal, a 1:1 tranilast 2,4-di′hydroxybenzoic acid complex and a 1:1 tranilast 2,4-dihydroxybenzoic acid cocrystal. Also disclosed are pharmaceutical compositions containing a tranilast complex or cocrystal of the invention and a pharmaceutically acceptable carrier. Methods of treatment using the tranilast complexes and cocrystais as well as the pharmaceutical compositions are disclosed. | 04-30-2015 |
Christopher Stephen Frampton, Stowmarket GB
Patent application number | Description | Published |
---|---|---|
20090318516 | SOLID FORMS OF (1R,2S,3R)-1-(2-(ISOXAZOL-3-YL)-1H-IMIDAZOL-4-YL)BUTANE-1,2,3,4-TETRAOL AND METHODS OF THEIR USE - Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and hydrates thereof are disclosed, as well as compositions comprising them and methods of their use. | 12-24-2009 |
Christopher Stephen Frampton, Suffolk GB
Patent application number | Description | Published |
---|---|---|
20120202825 | Soluble Salts of Thieno [2,3-d] Pyrimidine Derivatives - The present invention is directed to novel salts of thieno[2,3-d]pyrimidine derivatives, including 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidine salts. The present invention is also directed to compositions including such polymorphs and methods for using such salts, e.g., in the treatment of gastrointestinal and/or genitourinary disorders. | 08-09-2012 |
Christopher Stephen Frampton, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20110245306 | CO-CRYSTALS - The present invention relates to co-crystals of propiconazole and a co-crystal forming compound. | 10-06-2011 |
Dion Matthew Frederick Frampton, Tasmania AU
Patent application number | Description | Published |
---|---|---|
20120016144 | ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDS - The present invention relates generally to the field of recombinant fatty acid synthesis, particularly in transgenic plants. The application describes genes involved in fatty acid synthesis and provides methods and vectors for the manipulation of fatty acid composition of plant oils. In particular, the invention provides constructs for achieving the integration of multiple heterologous genes involved in fatty acid synthesis into the plant genome, such that the resulting plants produce altered levels of polyunsaturated fatty acids. Also described are methods for enhancing the expression of fatty acid biosynthesis enzymes by co-expressing a silencing suppressor within the plant storage organ. | 01-19-2012 |
Dion Matthew Frederick Frampton, Bonnet Hill AU
Patent application number | Description | Published |
---|---|---|
20150018571 | ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDS - The present invention relates generally to the field of recombinant fatty acid synthesis, particularly in transgenic plants. The application describes genes involved in fatty acid synthesis and provides methods and vectors for the manipulation of fatty acid composition of plant oils. In particular, the invention provides constructs for achieving the integration of multiple heterologous genes involved in fatty acid synthesis into the plant genome, such that the resulting plants produce altered levels of polyunsaturated fatty acids. Also described are methods for enhancing the expression of fatty acid biosynthesis enzymes by co-expressing a silencing suppressor within the plant storage organ. | 01-15-2015 |
Mark Frampton, Thorold CA
Patent application number | Description | Published |
---|---|---|
20100283183 | ENZYME-MEDICATED CROSS-LINKING OF SILICONE POLYMERS - Disclosure herein are methods of preparing cross-linked silicone polymers by contacting a silicone polymer and optionally a cross-linking agent with a hydrolytic enzyme under conditions for the cross-linking of the silicone polymer, wherein the silicone polymer has been modified to comprise functional groups that react with the hydrolytic enzyme. | 11-11-2010 |
Mark B. Frampton, Thorold CA
Patent application number | Description | Published |
---|---|---|
20150259478 | SILOXANE-CONTAINING HYBRID MATERIALS - The present application discloses siloxane-containing hybrid materials. For example, the present application discloses siloxane-containing hybrid materials comprising cyclic siloxanes or polyhedral siloxanes such as polymeric siloxane-containing hybrid materials comprising cyclic siloxanes or polyhedral siloxanes, methods for preparing such siloxane-containing hybrid materials, the use of such siloxane-containing hybrid materials for coating a substrate, coatings comprising the polymeric siloxane-containing hybrid materials, composites comprising a film of the polymeric siloxane-containing material coated on a substrate and compounds which are useful in preparing the siloxane-containing hybrid materials. | 09-17-2015 |
Michael John Frampton, Oxford GB
Patent application number | Description | Published |
---|---|---|
20100228022 | Reactive Organometallic Dendrimers - A process for modifying at least one dendron that is intended to form part of a dendrimer is disclosed. One reacts at least one reactable unsaturated group in a chemoselective manner to form a less unsaturated group. Also disclosed is a process for modifying dendrimers in a similar manner. | 09-09-2010 |
Simon James Frampton, Milano IT
Patent application number | Description | Published |
---|---|---|
20120134635 | OPTICAL CABLE WITH IMPROVED STRIPPABILITY - An optical cable includes a buffer tube housing at least one optical fiber, a sheath surrounding such buffer tube and at least one longitudinal strength member embedded in the sheath, in which at least one separation element is provided between a portion of the outer surface of the buffer tube and the inner surface of the sheath, laying in an axial plane not containing the at least one strength member. | 05-31-2012 |